Despite COVID-19, we are operating at full capacity and all project work is operating as usual.

Clinically predictive preclinical efficacy testing services at your disposal



Current news

New Lead Molecule for Novel Anti-Osteoporotic Drug Published

December 10, 2020

A new lead molecule (compound E197) for novel anti-osteoporotic drug has been identified at the Montpellier Cell Biology Research Center (CRBM), University of Montpellier, French National Center for…

Read More »

Pharmatest to attend 3rd Annual Advances in Immuno-Oncology US Congress

October 15, 2020

This week on Thursday October 15th our oncology experts will virtually travel and attend the 3rd Annual Advances in Immuno-Oncology USA Congress. The Congress includes over 300 attendees with more…

Read More »

ASBMR 2020 Virtual Annual Meeting

September 10, 2020

Pharmatest will be taking part of the virtual ASBMR 2020 Meeting starting on Friday, September 11. We are excited about this year’s scientific program packed with cutting-edge research in the bone,…

Read More »

Pharmatest at AACR 2020 virtual meeting

June 16, 2020

Pharmatest is very excited to participate in AACR virtual meeting II on June 22-24. Registration for this year’s Meeting is free! Please meet our Team attending AACR 2020 and ready to answer any of…

Read More »

Supporting the research related to COVID-19

April 30, 2020

In severe cases of SARS-CoV-2 infections, the immune system has been hyper-activated, triggering a cytokine release storm (CRS). CRS is body’s excessive immunological response against infection that…

Read More »

Pharmatest’s projects and safety during the COVID-19 outbreak

March 20, 2020

Pharmatest’s projects and safety during the COVID-19 outbreak To ensure the health and safety of Pharmatest’s employees, we have adopted the following precautionary policies until further notice: -…

Read More »